CANCER BIOMARK - Cancer Biomarkers
Publikationen
- 2023
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples
Möller, K., Knöll, M., Bady, E., Schmerder, M. J., Rico, S. D., Kluth, M., Hube-Magg, C., Blessin, N. C., Mandelkow, T., Lennartz, M., Menz, A., Luebke, A. M., Höflmayer, D., Fraune, C., Bernreuther, C., Lebok, P., Uhlig, R., Contreras, H., Weidemann, S., Gorbokon, N., Jacobsen, F., Clauditz, T. S., Steurer, S., Burandt, E., Minner, S., Sauter, G., Simon, R., Marx, A. H. & Krech, T., 2023, in: CANCER BIOMARK. 36, 2, S. 177-191 15 S.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
- 2017
Expression and genetic polymorphism of necroptosis related protein RIPK1 is correlated with severe hepatic ischemia-reperfusion injury and prognosis after hepatectomy in hepatocellular carcinoma patients
Yao, C., Li, G., Cai, M., Qian, Y., Wang, L., Xiao, L., Thaiss, F. & Shi, B., 19.07.2017, in: CANCER BIOMARK. 20, 1, S. 23-29 7 S.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung